HomeProductsBuilding BlocksHeterocyclic ScaffoldsQuinazolinesOlcegepant
Chemical structure of CAS 204697-65-4

Olcegepant

In Stock•Starting at $94 for 1 mg•Purity ≥ 98%
CAS No.204697-65-4
MDL No.N/A
MFC38H47Br2N9O5
MW869.60
InChI KeyITIXDWVDFFXNEG-JHOUSYSJSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98+%$94In Stock
5 mg98+%$199In Stock
10 mg98+%$306In Stock
25 mg98+%$558In Stock
50 mg98+%$888In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.204697-65-4
Product NameOlcegepant
Heavy Atom Count54Rotatable Bond Count12
Atom Stereo Count2Bond Stereo Count0
HBA8HBD5
TPSA176.470 ŲCharge0
Exact Mass867.20669Complexity1779.64
pKa8.855XLogP4.408

Related Articles

Studies related to this compound and its mechanism of action

A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences • Vol. 877, Issue 14-15 • 2009
PMID: 19346171DOI: 10.1016/j.jchromb.2009.03.019

Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.

The journal of headache and pain • Vol. 9, Issue 1 • 2008
PMID: 18217201PMC: PMC2245994DOI: 10.1007/s10194-008-0011-4

Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment.

IDrugs : the investigational drugs journal • Vol. 10, Issue 8 • 2007
PMID: 17665333

Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery.

Naunyn-Schmiedeberg's archives of pharmacology • Vol. 374, Issue 3 • 2006
PMID: 17103145DOI: 10.1007/s00210-006-0108-8

Documentation